法院驳回辉瑞限制交易禁令，Metsera并购案战火持续升级

研发客2025-11-06

美国时间2025年11月5日，特拉华州衡平法院副大法官Morgan T. Zurn在听证会上驳回了辉瑞要求阻止诺和诺德收购Metsera的临时限制令请求。Zurn在当庭裁决中称，辉瑞于 10 月 31 日向衡平法院（Court of Chancery）提起诉讼，并于周一在特拉华州地区法院提起反垄断诉讼，但未能证明Metsera董事会在评估诺和诺德收购要约时存在不诚信行为。因此，她无法认定...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2581871035?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-06 10:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2581871035","market":"us","top_or_hot":-1,"title":"法院驳回辉瑞限制交易禁令，Metsera并购案战火持续升级","media":"研发客","content":"<div>\n<p>美国时间2025年11月5日，特拉华州衡平法院副大法官Morgan T. Zurn在听证会上驳回了辉瑞要求阻止诺和诺德收购Metsera的临时限制令请求。Zurn在当庭裁决中称，辉瑞于 10 月 31 日向衡平法院（Court of Chancery）提起诉讼，并于周一在特拉华州地区法院提起反垄断诉讼，但未能证明Metsera董事会在评估诺和诺德收购要约时存在不诚信行为。因此，她无法认定...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106111235a6e4bc11&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>法院驳回辉瑞限制交易禁令，Metsera并购案战火持续升级</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n法院驳回辉瑞限制交易禁令，Metsera并购案战火持续升级\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-06 10:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106111235a6e4bc11&s=b><strong>研发客</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国时间2025年11月5日，特拉华州衡平法院副大法官Morgan T. Zurn在听证会上驳回了辉瑞要求阻止诺和诺德收购Metsera的临时限制令请求。Zurn在当庭裁决中称，辉瑞于 10 月 31 日向衡平法院（Court of Chancery）提起诉讼，并于周一在特拉华州地区法院提起反垄断诉讼，但未能证明Metsera董事会在评估诺和诺德收购要约时存在不诚信行为。因此，她无法认定...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106111235a6e4bc11&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1023059063.AUD","symbol_name":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106111235a6e4bc11&s=b","article_id":"2581871035","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106111235a6e4bc11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2581871035","pubTimestamp":1762397520,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美国时间2025年11月5日，特拉华州衡平法院副大法官Morgan T. Zurn在听证会上驳回了辉瑞要求阻止诺和诺德收购Metsera的临时限制令请求。Zurn在当庭裁决中称，辉瑞于 10 月 31 日向衡平法院提起诉讼，并于周一在特拉华州地区法院提起反垄断诉讼，但未能证明Metsera董事会在评估诺和诺德收购要约时存在不诚信行为。因此，她无法认定Metsera退出与辉瑞的交易构成合同条款下的不当终止。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4592":"伊斯兰概念","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","BK4588":"碎股","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","PFE":"辉瑞","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","NVO":"诺和诺德","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","BK4007":"制药","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4581":"高盛持仓","BK4599":"减肥药","BK4532":"文艺复兴科技持仓","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","SG9999001176.USD":"United Global Healthcare Acc USD","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4585":"ETF&股票定投概念","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK4534":"瑞士信贷持仓","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999002232.USD":"Allianz Global High Payout USD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","MTSR":"Metsera Inc.","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF"},"translate_title":"Court rejects Pfizer's ban on restricting transactions, Metsera merger case continues to escalate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1.5,"NVO":0.9,"MTSR":1.5},"content_text":"美国时间2025年11月5日，特拉华州衡平法院副大法官Morgan T. Zurn在听证会上驳回了辉瑞要求阻止诺和诺德收购Metsera的临时限制令请求。Zurn在当庭裁决中称，辉瑞于 10 月 31 日向衡平法院（Court of Chancery）提起诉讼，并于周一在特拉华州地区法院提起反垄断诉讼，但未能证明Metsera董事会在评估诺和诺德收购要约时存在不诚信行为。因此，她无法认定Metsera退出与辉瑞的交易构成合同条款下的不当终止。当前，虽然这一裁决对诺和诺德有利，但并不意味着诺和诺德接下来的收购之路会一帆风顺。此前美国联邦贸易委员会（FTC）的一名官员致信诺和诺德和Metsera的律师称，诺和诺德目前对Metsera的收购提议可能违反了并购相关的程序法。诺和诺德全球媒体和利益相关者沟通副总裁Ambre James-Brown在接受Fierce采访时表示：“相信我们的收购要约符合Metsera股东的最大利益，此次法院驳回辉瑞毫无根据的诉讼请求的决定是正确的。”11月5日，辉瑞在官网发表的一份声明回应称：“此次法院的裁决并未解决辉瑞提出的所有核心法律争议的实质性内容，辉瑞将继续通过正在进行的诉讼程序以及在特拉华州联邦法院提起的平行反垄断诉讼，继续积极维护其权益。”值得注意的是，辉瑞已将报价提升至81亿美元，展现出谈判意愿，而Metsera在周二的新闻稿中明确表示，诺和诺德更新后100亿美元的报价更具优势。随着法律程序的持续推进与报价的攀升，两大制药巨头的百亿收购争夺战进入了更为关键的博弈阶段。拓展阅读黑马Metsera：为辉瑞青睐的肽技术平台有何玄机？总第2639期访问研发客网站，深度报道和每日新闻抢鲜看www.PharmaDJ.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581871035","isCrawlerRequest":true}